Advances in DNA and mRNA-Based Strategies for Cancer Immunotherapy: Part A

1st Edition, Volume 165 - June 18, 2025
Latest edition
Editors: Arun Kumar Singh, Neeraj Mishra, Sumel Ashique, Pranav Kumar Prabhakar
Language: English

Advances in DNA and mRNA-Based Strategies for Cancer Immunotherapy, Volume 165 in the Advances in Immunology series, presents current developments and comprehensive reviews in DN… Read more

Advances in DNA and mRNA-Based Strategies for Cancer Immunotherapy, Volume 165 in the Advances in Immunology series, presents current developments and comprehensive reviews in DNA and mRNA vaccines: Significant therapeutic approach against cancer management, Nanoparticles for mRNA-based cancer immunotherapy, Nucleic acid Delivery as a therapeutic approach in cancer immunotherapy, Plasmid DNA and mRNA: Delivery approaches and challenges, Viral & Non-viral Delivery of mRNA against Cancer Cell, Progress in Modifying and Delivering mRNA therapies for Cancer Immunotherapy, and more.

Other chapters cover mRNA-Based Cancer Vaccines: A Novel Approach to Melanoma Treatment, Therapeutic mRNAs for cancer immunotherapy: from structure to delivery, Harnessing the immune system: Insights into cancer vaccines, Lipid Nanoparticle-Mediated mRNA Delivery in Cancer Immunotherapy, Immunotherapy Perspectives in the Era of B-Cell Editing in Cancer Treatment, Personalized Precision: Revolutionizing Cancer Treatment with mRNA-Based Vaccines in Melanoma Therapy, Revolutionizing Cancer Treatment: Exploring Novel Immunotherapeutics, Checkpoints, bispecifics, and Vaccines in Development, and more.

Arun Kumar Singh

Dr. Arun Kumar Singh is an assistant professor in the Department of Pharmacy at Vivekanand Global University, Jaipur. He completed both his MPharm in Pharmaceutics and his PhD at Galgotias University, Greater Noida. His research strengths lie in AI-driven cancer research, nano-formulation, and the intersection of blockchain, IoT, machine learning, big data, and neuroscience with pharmaceutical science. He has authored books and contributed chapters on big data and cancer, and his work includes reviews published in reputable journals. His research appears across publishers such as IOP, Elsevier, CRC Press, and Wiley, reflecting a broad publication record and ongoing contributions to AI-enabled oncology and advanced drug delivery.

Affiliations and expertise

Assistant Professor, Department of Pharmacy, Vivekanand Global University Jaipur Rajasthan, India

Neeraj Mishra

Dr. Neeraj Mishra is a Professor at the Amity Institute of Pharmacy, Gwalior, where he has served since July 2019. He has over 20 years of teaching and research experience and more than 150 international and national publications in novel, localized, targeted, and controlled drug delivery systems, including nano- and microparticles for the treatment of breast and colon cancer and neurodegenerative disorders. Dr. Mishra has authored 25 books and 45 book chapters with leading publishers such as Elsevier, Bentham, Springer, and Wiley, and holds five patents (three international and two Indian). His honors include the Distinguished Professor Awards (2019, 2021), Outstanding Scientist Award (2020), and Best Academician Award (2023). In 2025, he was recognized as one of the World’s Top 2% Scientists by Stanford University and Elsevier.

Affiliations and expertise

Professor and Head of Department, Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, India

Sumel Ashique

Sumel Ashique has been working as an assistant professor at Bengal College of Pharmaceutical Sciences & Research, Durgapur 713212, West Bengal, India, West Bengal, India. He has 3.5 years of teaching experience. He has achieved 70+ publications of International and national accredited reputed journals (Scopus, UGC). He has knowledge in drug delivery, nanotechnology and targeted treatment strategy. He has also 6 granted patents from IP and Australia & 20 book chapters have been submitted to well-known publishers like Springer, Elsevier, Bentham and Taylor & Francis.

Affiliations and expertise

Asst. Professor, Department of Pharmaceutical Technology, Bharat Technology, Uluberia, West Bengal, India

Pranav Kumar Prabhakar

Dr. Prabhakar is a Professor and Head in the Department of Biotechnology at Nagaland University, Kohima, India. He has been recognized among leading global scientists by Stanford’s annual Top Scientists list. He earned his PhD in Biotechnology from IIT Madras. His research centers on molecular mechanisms and strategies for oral insulin delivery and mimicking signaling pathways in metabolic disorders using natural products. He is a member of the Royal Society of Chemistry and the Asia-Pacific Chemical, Biological & Environmental Engineering Society, and contributes as an editorial board member and reviewer for multiple journals. Dr. Prabhakar has received honors including a travel grant to a European conference supported by IIT Madras and CSIR, and funding approved by the Department of Science and Technology. He has published a substantial body of work, authored or edited several books, contributed many chapters, and given numerous talks and poster presentations at conferences.

Affiliations and expertise

Professor and Head, Department of Biotechnology, School of Engineering and Technology, Nagaland University, Meriema, Kohima, Nagaland, India

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Advances in DNA and mRNA-Based Strategies for Cancer Immunotherapy: Part A

Description

Key features

Readership

Table of contents

Product details

About the editors

Arun Kumar Singh

Neeraj Mishra

Sumel Ashique

Pranav Kumar Prabhakar

View book on ScienceDirect